SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-023726
Filing Date
2022-08-22
Accepted
2022-08-22 16:05:51
Documents
54
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1010474
2 ex31-1.htm EX-31.1 18708
3 ex31-2.htm EX-31.2 18516
4 ex32-1.htm EX-32.1 7870
5 ex32-2.htm EX-32.2 7957
  Complete submission text file 0001493152-22-023726.txt   5670417

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rspi-20220630.xsd EX-101.SCH 50894
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rspi-20220630_cal.xml EX-101.CAL 39376
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rspi-20220630_def.xml EX-101.DEF 212747
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rspi-20220630_lab.xml EX-101.LAB 397943
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rspi-20220630_pre.xml EX-101.PRE 301467
48 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 878752
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 221183804
SIC: 2834 Pharmaceutical Preparations